Effect of inhaled glucocorticoids and β2 agonists on vertebral fracture risk in COPD patients: The EOLO study

S. Gonnelli, C. Caffarelli, S. Maggi, G. Guglielmi, P. Siviero, S. Rossi, G. Crepaldi, R. Nuti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Effect of inhaled glucocorticoids and β2 agonists on vertebral fracture risk in COPD patients: The EOLO study'. Together they form a unique fingerprint.

Medicine & Life Sciences